From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma
Immunotherapy has revolutionized the treatment landscape for many cancer types. The treatment for renal cell carcinoma (RCC) has especially evolved in recent years, from cytokine-based immunotherapies to immune checkpoint inhibitors. Although clinical benefit from immunotherapy is limited to a subse...
Saved in:
Main Authors: | Jonathan Anker, Justin Miller, Nicole Taylor, Natasha Kyprianou, Che-Kai Tsao |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/951e1e7f7a2f46bbb26efa30f2a3f187 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrative Analysis of Immune-Related Genes in the Tumor Microenvironment of Renal Clear Cell Carcinoma and Renal Papillary Cell Carcinoma
by: Bin Zheng, et al.
Published: (2021) -
Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
by: Lu Zhang, et al.
Published: (2021) -
Immunosuppressive microenvironment in oral cancer: implications for cancer immunotherapy
by: Shalini K. Sureshbabu, et al.
Published: (2021) -
Multi-Omics Analysis of Novel Signature for Immunotherapy Response and Tumor Microenvironment Regulation Patterns in Urothelial Cancer
by: Guangdi Chu, et al.
Published: (2021) -
Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?
by: Patricia Martin-Romano, et al.
Published: (2021)